Quick Takeaways
- Sukumar Nagendran has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $5,068,388.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Sukumar Nagendran
- Location
- Bannockburn, IL
- Summary
- The estimated net worth of Sukumar Nagendran is at least $5,068,388 dollars as of 13 Apr 2026. Sukumar Nagendran is the President and Head of R&D, Director of Taysha Gene Therapies, Inc. and owns shares of Taysha Gene Therapies, Inc. (TSHA) stock worth about $5.07M.
- Signature
- /s/ Kamran Alam, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Sukumar Nagendran and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Taysha Gene Therapies, Inc. ($5,068,388).
- Past-year value change for that position: -$4,885,979.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Sukumar Nagendran
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| TSHA | Taysha Gene Therapies, Inc. | President and Head of R&D, Director | $5,068,388 | -$4,885,979 | -49% | 10 Apr 2026 |
| SLDB | Solid Biosciences Inc. | Director | 12 Jun 2025 |
Insider Transactions Reported by Sukumar Nagendran:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.